Grifols, S.A

(NASDAQ:GRFS)

Latest On Grifols, S.A (GRFS):

Date/Time Type Description Signal Details
2023-05-13 23:16 ESTNewsGrifols: Upside After A Smashing Q1 2023 - I Say 'Buy'N/A
2023-05-10 09:51 ESTNewsGrifols, S.A. (GRFS) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 09:51 ESTNewsGrifols, S.A. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-09 21:01 ESTNewsGrifols S.A. reports Q1 results; raises FY23 guidanceN/A
2023-05-08 18:06 ESTNewsGrifols names new CEO ending founding family’s leadershipN/A
2023-05-08 18:06 ESTNewsGrifols S.A. Q1 2023 Earnings PreviewN/A
2023-03-06 22:10 ESTNewsGrifols, Selagine team up to develop immunoglobulin eye dropsN/A
2023-03-03 14:59 ESTNewsGrifols downgraded at Morgan Stanley citing slower margin recoveryN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. (GRFS) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-27 22:34 ESTNewsGrifols S.A. FY 2022 Earnings PreviewN/A
2023-02-23 08:51 ESTNewsGrifols: A Favorite For Some, Speculative Buy For MeN/A
2023-02-15 18:35 ESTNewsGrifols cuts 8% staff mainly in U.S. as cost savings plan takes effectN/A
2022-12-07 04:30 ESTNewsGrifols upgraded to Overweight at Morgan StanleyN/A
2022-11-18 23:56 ESTNewsGrifols Needs To DeleverageN/A
2022-11-11 02:38 ESTNewsGrifols S.A. reports Q3 resultsN/A
2022-09-08 04:06 ESTNewsGrifols inks 15-year deal with Canada for plasma-derived therapiesN/A
2022-07-29 21:31 ESTNewsGrifols: Every Cloud Has A Silver LiningN/A
2022-05-10 18:31 ESTNewsGrifols: Long OnlyN/A
2022-05-09 20:47 ESTNewsGrifols stock slumps on Spain's stock exchange paring gains seen after Q1 resultsN/A
2022-03-31 03:27 ESTNewsGrifols jumps on report on takeover speculation (update)N/A
2022-03-15 13:03 ESTNewsGrifols ABvac40 vaccine for Alzheimer's shows safety/response in phase 2 interim dataN/A
2022-02-25 00:55 ESTNewsGrifols, Endpoint Health team up to develop Antithrombin III for SepsisN/A
2022-02-10 19:31 ESTNewsGrifols: Short-Term Turbulence But Long-Term UpsideN/A
2022-02-07 14:28 ESTNewsGrifols extends losses as JPMorgan points to downside risk to consensusN/A
2021-12-28 18:43 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-09-22 13:48 ESTNewsGrifols consolidates footprint in blood plasma with agreement to acquire BiotestN/A
2021-07-22 12:25 ESTNewsGrifols launches hepatitis B treatment HyperHEP BN/A
2021-07-22 12:25 ESTNewsGrifols sees revenue contribution from new product launches to ramp by 2030N/A
2021-07-22 12:25 ESTNewsGrifols presents at 2021 investor and analyst day - slideshowN/A
2021-07-22 12:16 ESTNewsGrifols: Valuation Discount Remains Wide Despite An Upbeat Capital Markets DayN/A
2021-06-03 06:11 ESTDividendA dividend of $0.46 has been announced on Nov 30, -0001. It will be paid Jun 14, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-04-29 02:40 ESTNewsGrifols shares rise after Andorra Development and Investment dealN/A
2021-04-21 10:06 ESTNewsGrifols: The Plasma-Supply Disruption Provides An Attractive Entry PointN/A
2021-03-18 23:26 ESTAnalyst RatingThe Analyst Target Price has increased from $27.19 to $27.38.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $1.56 is estimated for the 2022 year.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-17 22:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.31 to $27.19.Neutral
2021-03-16 22:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.41 to $27.31.Neutral
2021-03-13 21:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.49 to $32.41.Neutral
2021-03-13 05:02 ESTAnalyst RatingThe Analyst Target Price has increased from $32.34 to $32.49.Buy
2021-03-12 13:01 ESTAnalyst RatingThe Analyst Target Price has increased from $31.97 to $32.34.Buy
2021-03-12 05:18 ESTAnalyst RatingThe Analyst Target Price has increased from $31.9 to $31.97.Buy
2021-03-11 01:24 ESTAnalyst RatingThe Analyst Target Price has increased from $31.77 to $31.9.Buy
2021-03-10 05:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.97 to $31.77.Neutral
2021-03-09 01:14 ESTAnalyst RatingThe Analyst Target Price has increased from $31.93 to $31.97.Buy
2021-03-07 09:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.08 to $31.93.Neutral
2021-03-05 21:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.27 to $32.08.Neutral
2021-03-05 12:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.36 to $32.27.Neutral
2021-03-04 01:27 ESTAnalyst RatingThe Analyst Target Price has increased from $32.26 to $32.36.Buy

About Grifols, S.A (GRFS):

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

GRFS Quotes by TradingView

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GRFS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 23,655
  • Last Split Factor2:1
  • Last Split Date2016-01-04
  • Fiscal Year EndDecember
  • IPO Date2006-05-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.grifols.com
View More

Valuation

  • Trailing PE 27.04
  • Forward PE 11.99
  • Price/Sales (Trailing 12 Mt.) 1.73
  • Price/Book (Most Recent Quarter) 1.81
  • Enterprise Value Revenue 4.17
  • Enterprise Value EBITDA 15.63
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.34
  • Next Year EPS Estimate $1.57
  • Next Quarter EPS Estimate $0.32
  • Profit Margin 12%
  • Return on Assets 5%
  • Return on Equity 10%
  • Earnings Per Share $0.60
  • Revenue Per Share $0
  • Gross Profit 2.51 billion
  • Quarterly Earnings Growth -3.8%
View More

Highlights

  • Market Capitalization 14.95 billion
  • PE Ratio 37.23
  • PEG Ratio 1.78
  • Analyst Target Price $27.38
  • Book Value Per Share $3.56
View More

Share Statistics

  • Shares Outstanding 684.54 million
  • Shares Float 856.69 million
  • % Held by Insiders <1%
  • % Held by Institutions 45.62%
  • Shares Short 3.8 million
  • Shares Short Prior Month 3.72 million
  • Short Ratio 4.17
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.05
  • 52 Week High $21.62
  • 52 Week Low $14.81
  • 50 Day Moving Average 16.54
  • 200 Day Moving Average 17.73
View More

Dividends

  • Forward Annual Dividend Rate $0.42
  • Forward Annual Dividend Yield 2.55%
  • Payout Ratio 16%
  • Dividend Date 2020-11-09
  • ExDividend Date 2020-10-30
  • Dividend Per Share $0.47
  • Dividend Yield 0%
View More

Grifols, S.A (GRFS) Dividend Calendar:

GRFS's last dividend payment was made to shareholders on November 9, 2020.
Grifols, S.A pays out 16% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-06-032021-06-142021-06-040000-00-00$0.46
2020-10-302020-11-092020-11-02$0.2
2019-12-022019-12-112019-12-032019-10-31$0.22
2019-06-072019-06-182019-06-102019-05-29$0.18
2018-11-302018-12-112018-12-032018-11-07$0.23
2018-06-012018-06-122018-06-042018-05-25$0.25
2017-12-012017-12-122017-12-04$0.21
2017-05-302017-06-082017-06-01$0.16
2016-12-052016-12-142016-12-07$0.19
2015-12-102015-12-172015-12-14$0.38
2015-06-082015-06-152015-06-10$0.34
2016-06-020000-00-002016-06-060000-00-00$0.16
2016-06-022016-06-06$0.16

Grifols, S.A (GRFS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$1.31 billion$0.29$0.2515.82%
2020-09-302020-11-05$N/A$0.37$0.356.67%
2020-06-302020-07-30$N/A$0.36$0.37-1.33%
2020-03-312020-04-21$1.29 billion$0.24$0.30-18.58%
2019-12-312020-02-27$1.53 billion$0.31$0.31-1.63%
2019-09-302019-10-29$1.43 billion$0.28$0.30-7.05%
2019-06-302019-07-31$1.43 billion$0.33$0.320.12%
2019-03-312019-05-07$1.3 billion$0.25$0.25-1.32%
2018-12-312019-02-28$1.4 billion$0.24$0.31-22.87%
2018-09-302018-11-05$1.32 billion$0.29$0.31-5.83%
2018-06-302018-07-27$1.28 billion$0.34$0.326.69%
2018-03-312018-05-03$1.26 billion$0.28$0.29-3.76%
2017-12-312018-02-28$1.35 billion$0.29$0.31-8.1%
2017-09-302017-11-02$1.34 billion$0.28$0.30-4.31%
2017-06-302017-07-28$1.37 billion$0.28$0.281.53%
2017-03-312017-05-03$1.14 billion$0.27$0.261.71%
2016-12-312017-02-28$956.29 million$0.25$0.253.59%
2016-09-302016-11-08$1.16 billion$0.28$0.2511.6%
2016-06-302016-07-28$1.06 billion$0.26$0.27-5.56%
2016-03-312016-05-05$1.09 billion$0.23$0.24-4.25%
2015-12-312016-02-29$1.07 billion$0.24$0.27-11.48%
2015-09-302015-11-04$1.09 billion$0.26$0.2218.18%
2015-06-302015-07-30$1.14 billion$0.22$0.23-4.35%
2015-03-312015-05-07$975.7 million$0.25$0.244.17%
2014-12-312015-02-26$981.53 million$0.28$0.280%
2014-09-302014-11-04$873.66 million$0.28$0.30-6.67%
2014-06-302014-07-31$1.11 billion$0.32$0.306.67%
2014-03-312014-05-06$1.1 billion$0.24$0.28-14.29%
2013-12-312014-02-27$1.01 billion$0.16
2013-09-302013-11-05$973.55 million$0.16
2013-06-302013-07-31$920.25 million$0.18
2013-03-312013-05-02$876.23 million$0.18
2012-12-312013-02-28$936.82 million$0.12
2012-09-302012-10-31$851.15 million$0.07$0.13-46.15%
2012-06-302012-07-31$779.05 million$0.08$0.27-70.37%
2012-03-312012-04-24$888.95 million$0.13
2011-12-312012-02-29$708.12 million$0.00
2011-09-302011-11-11$698.63 million$0.05
2011-06-302011-07-28$551.92 million-$0.03

Grifols, S.A (GRFS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GRFS) Chart:

Grifols, S.A (GRFS) News:

Below you will find a list of latest news for Grifols, S.A (GRFS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GRFS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-1810CALL0 01221.63TRUE00
2025-07-1820CALL0 0775.3TRUE00
2025-07-1830CALL0 0561.93TRUE00
2025-07-1840CALL0 0377.46TRUE00
2025-07-1850CALL0 0292.46TRUE00
2025-07-1860CALL0 0162.99TRUE00
2025-07-1870CALL0 076.02TRUE00
2025-07-1880.56CALL0 349.47TRUE00
2025-07-1890.22CALL3 3039.07FALSE0.020.1
2025-07-18100.1CALL0 644.1FALSE00
2025-07-18110CALL0 0178.42FALSE00
2025-07-18120CALL0 0164.57FALSE00
2025-07-18130CALL0 0185.43FALSE00
2025-07-18140CALL0 0203.77FALSE00
2025-07-18150CALL0 0220.15FALSE00
2025-07-18160CALL0 0278.43FALSE00
2025-07-1810PUT0 0887.6FALSE00
2025-07-1820PUT0 0569.66FALSE00
2025-07-1830PUT0 0419.37FALSE00
2025-07-1840PUT0 0320.66FALSE00
2025-07-1850PUT0 0246.33FALSE00
2025-07-1860PUT0 0185.57FALSE00
2025-07-1870PUT0 3132.57FALSE00
2025-07-1880.12PUT10 10245.94FALSE-0.06-0.33
2025-07-1890.45PUT0 4039.63TRUE00
2025-07-18100PUT0 058.92TRUE00
2025-07-18110PUT0 0163.38TRUE00
2025-07-18120PUT0 0168.86TRUE00
2025-07-18130PUT0 0197.26TRUE00
2025-07-18140PUT0 0168.86TRUE00
2025-07-18150PUT0 0240.54TRUE00
2025-07-18160PUT0 0177.82TRUE00
2025-08-1510CALL0 0969.6TRUE00
2025-08-1520CALL0 0533.69TRUE00
2025-08-1530CALL0 5385.77TRUE00
2025-08-1540CALL0 0251TRUE00
2025-08-1550CALL0 7186.67TRUE00
2025-08-1563CALL0 9114.91TRUE00
2025-08-1571.91CALL0 66971.66TRUE00
2025-08-1580.76CALL0 10875.87TRUE00
2025-08-1590CALL0 5242.46FALSE00
2025-08-15100.57CALL0 23355.92FALSE00
2025-08-15110CALL0 6052.73FALSE00
2025-08-15120.05CALL0 373.01FALSE00
2025-08-15130CALL0 1112.22FALSE00
2025-08-15140CALL0 0123.91FALSE00
2025-08-15150CALL0 0134.36FALSE00
2025-08-15160CALL0 0143.82FALSE00
2025-08-1510PUT0 0588.53FALSE00
2025-08-1520PUT0 0377.18FALSE00
2025-08-1530PUT0 0277.28FALSE00
2025-08-1540PUT0 4211.65FALSE00
2025-08-1550PUT0 7162.19FALSE00
2025-08-1560PUT0 40121.72FALSE00
2025-08-1570.15PUT0 25268.93FALSE00
2025-08-1580.23PUT0 33748.45FALSE00
2025-08-1590.59PUT0 2122.35TRUE00
2025-08-15100PUT0 2096.98TRUE00
2025-08-15110PUT0 0189.64TRUE00
2025-08-15120PUT0 087.39TRUE00
2025-08-15130PUT0 0149.88TRUE00
2025-08-15140PUT0 0149.4TRUE00
2025-08-15150PUT0 091.04TRUE00
2025-08-15160PUT0 0176.4TRUE00
2025-11-2110CALL0 0679.99TRUE00
2025-11-2120CALL0 0344.53TRUE00
2025-11-2130CALL0 0239.86TRUE00
2025-11-2140CALL0 3240.31TRUE00
2025-11-2150CALL0 0102.69TRUE00
2025-11-2160CALL0 0175.6TRUE00
2025-11-2170CALL0 055.31TRUE00
2025-11-2180CALL0 437.13TRUE00
2025-11-2191.05CALL0 1845.43FALSE00
2025-11-21100CALL0 145.33FALSE00
2025-11-21110CALL0 052.04FALSE00
2025-11-21120CALL0 060.9FALSE00
2025-11-21130CALL0 061.85FALSE00
2025-11-21140CALL0 062.4FALSE00
2025-11-21150CALL0 081.32FALSE00
2025-11-21160CALL0 086.79FALSE00
2025-11-2110PUT0 0341.79FALSE00
2025-11-2120PUT0 0217.97FALSE00
2025-11-2130PUT0 0159.46FALSE00
2025-11-2140PUT0 0120.98FALSE00
2025-11-2150PUT0 191.93FALSE00
2025-11-2160PUT0 10359.96FALSE00
2025-11-2170.5PUT0 8954.79FALSE00
2025-11-2180.75PUT0 7936.83FALSE00
2025-11-2190PUT0 025.37TRUE00
2025-11-21100PUT0 055.08TRUE00
2025-11-21110PUT0 072.3TRUE00
2025-11-21120PUT0 066.34TRUE00
2025-11-21130PUT0 0112.15TRUE00
2025-11-21140PUT0 051.69TRUE00
2025-11-21150PUT0 090.34TRUE00
2025-11-21160PUT0 070.95TRUE00
2025-12-1935.7CALL0 115148.53TRUE00
2025-12-1940CALL0 0137.45TRUE00
2025-12-1950CALL0 48122.84TRUE00
2025-12-1960CALL0 1891.27TRUE00
2025-12-1972.3CALL0 8070.19TRUE00
2025-12-1981.1CALL0 1762.9TRUE00
2025-12-1991.1CALL0 1642.81FALSE00
2025-12-19100.65CALL2 19551.87FALSE0.650
2025-12-19110CALL0 055.04FALSE00
2025-12-19120CALL0 8456.72FALSE00
2025-12-19150.05CALL0 14658.71FALSE00
2025-12-1930PUT0 0145.77FALSE00
2025-12-1940PUT0 0110.39FALSE00
2025-12-1950PUT0 42364.22FALSE00
2025-12-1960PUT0 458.05FALSE00
2025-12-1970PUT0 15049.37FALSE00
2025-12-1980.95PUT0 434.93FALSE00
2025-12-1991.45PUT0 213.15TRUE00
2025-12-19100PUT0 027.66TRUE00
2025-12-19110PUT0 033.79TRUE00
2025-12-19120PUT0 0102.08TRUE00
2025-12-19150PUT0 0116.49TRUE00
2026-02-2010CALL0 0626.35TRUE00
2026-02-2020CALL0 0293.57TRUE00
2026-02-2030CALL0 0143.54TRUE00
2026-02-2040CALL0 0218.49TRUE00
2026-02-2050CALL0 0177.54TRUE00
2026-02-2060CALL0 0151.83TRUE00
2026-02-2070CALL0 048.57TRUE00
2026-02-2080CALL0 070.26TRUE00
2026-02-2090CALL0 045.65FALSE00
2026-02-20100CALL0 055.42FALSE00
2026-02-20110CALL0 059.58FALSE00
2026-02-20120CALL0 052.8FALSE00
2026-02-20130CALL0 068.23FALSE00
2026-02-20140CALL0 057.46FALSE00
2026-02-20150CALL0 062.06FALSE00
2026-02-20160CALL0 070.65FALSE00
2026-02-20170CALL0 074.57FALSE00
2026-02-2010PUT0 0268.62FALSE00
2026-02-2020PUT0 0170.49FALSE00
2026-02-2030PUT0 0124.13FALSE00
2026-02-2040PUT0 093.6FALSE00
2026-02-2050PUT0 070.5FALSE00
2026-02-2060PUT0 052.96FALSE00
2026-02-2070.5PUT0 141.75FALSE00
2026-02-2081.05PUT0 233.55FALSE00
2026-02-2091.6PUT0 216.71TRUE00
2026-02-20102.15PUT0 248.56TRUE00
2026-02-20110PUT0 060.45TRUE00
2026-02-20120PUT0 081.3TRUE00
2026-02-20130PUT0 088.93TRUE00
2026-02-20140PUT0 052.92TRUE00
2026-02-20150PUT0 093.7TRUE00
2026-02-20160PUT0 0103.51TRUE00
2026-02-20170PUT0 078.96TRUE00

Latest GRFS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST24$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST142$11.835
Jun 13, 2022 7:59 PM EST10$11.83

Grifols, S.A (GRFS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001082/0000315066-19-001082-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001598/0000315066-19-001598-index.htm
2018-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918030037/0001104659-18-030037-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918031927/0001104659-18-031927-index.htm
2018-05-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918035864/0001104659-18-035864-index.htm
2018-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918037898/0001104659-18-037898-index.htm
2018-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918038773/0001104659-18-038773-index.htm
2018-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1438569/000110465918040970/0001104659-18-040970-index.htm
2018-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918047551/0001104659-18-047551-index.htm
2018-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918048670/0001104659-18-048670-index.htm
2018-09-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918055714/0001104659-18-055714-index.htm
2018-10-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918060259/0001104659-18-060259-index.htm
2018-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918064237/0001104659-18-064237-index.htm
2018-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065575/0001104659-18-065575-index.htm
2018-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065887/0001104659-18-065887-index.htm
2018-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069526/0001104659-18-069526-index.htm
2018-11-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069680/0001104659-18-069680-index.htm
2018-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918073562/0001104659-18-073562-index.htm
2018-12-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918075244/0001104659-18-075244-index.htm
2019-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919011270/0001104659-19-011270-index.htm
2019-03-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919013238/0001104659-19-013238-index.htm
2019-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919018669/0001104659-19-018669-index.htm
2019-04-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919020063/0001104659-19-020063-index.htm
2019-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919021489/0001104659-19-021489-index.htm
2019-04-2320-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919023085/0001104659-19-023085-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919026164/0001104659-19-026164-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919027308/0001104659-19-027308-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919031663/0001104659-19-031663-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919033920/0001104659-19-033920-index.htm
2019-07-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919039379/0001104659-19-039379-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919040426/0001104659-19-040426-index.htm
2019-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919042789/0001104659-19-042789-index.htm
2019-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919056835/0001104659-19-056835-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919057088/0001104659-19-057088-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919058031/0001104659-19-058031-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919062979/0001104659-19-062979-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919064554/0001104659-19-064554-index.htm
2019-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919065722/0001104659-19-065722-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070538/0001104659-19-070538-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070539/0001104659-19-070539-index.htm
2020-02-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920022273/0001104659-20-022273-index.htm
2020-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920026130/0001104659-20-026130-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920038405/0001104659-20-038405-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920039290/0001104659-20-039290-index.htm
2020-04-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465920043470/0001104659-20-043470-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920049070/0001104659-20-049070-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920057912/0001104659-20-057912-index.htm
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920084649/0001104659-20-084649-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920088132/0001104659-20-088132-index.htm
2020-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102386/0001104659-20-102386-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102797/0001104659-20-102797-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920110940/0001104659-20-110940-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920113682/0001104659-20-113682-index.htm
2020-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920116641/0001104659-20-116641-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920121561/0001104659-20-121561-index.htm